Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, Par Value $0.001
-
Shares outstanding
-
12,939,536
-
Total 13F shares
-
15,449,518
-
Share change
-
-1,820,851
-
Total reported value
-
$44,457,051
-
Price per share
-
$2.88
-
Number of holders
-
63
-
Value change
-
-$10,911,286
-
Number of buys
-
27
-
Number of sells
-
32
Institutional Holders of Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) as of Q4 2019
As of 31 Dec 2019,
Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,449,518 shares.
The largest 10 holders included
NEA Management Company, LLC, Aisling Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, MORGAN STANLEY, and GSA CAPITAL PARTNERS LLP.
This page lists
63
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.